Viewing Study NCT04391595


Ignite Creation Date: 2025-12-24 @ 1:30 PM
Ignite Modification Date: 2026-02-03 @ 3:56 PM
Study NCT ID: NCT04391595
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-28
First Post: 2020-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
Sponsor: Nader Sanai
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
None GBM View
None Glioma View
Keywords: